Veterinary Pain Management Market Anticipated to Reach $1996.94 Million by 2027 – Exclusive Report by Mordor Intelligence

Mordor Intelligence
In January 2022, the United States Food and Drug Administration (FDA) approved Zorbium (buprenorphine transdermal solution) from Elanco Animal Health as it expands its pain management offerings while addressing an unmet need for veterinary practices.

Veterinary Pain Management Market Overview

The Veterinary Pain management market was valued at USD 1,352.19 million in 2021 and it is expected to reach USD 1,996.94 million by 2027 at a CAGR of 6.61% during the forecast period, 2022-2027. Some of the factors driving the Veterinary Pain Management market growth include the high prevalence of inflammatory and painful diseases in the animal population. According to an article published by Veterinary Practice News in June 2020, the prevalence of osteoarthritis in dogs was found to be 20%, globally. Similarly, according to an article published by American Animal Health Association in April 2021, approximately 6 million dogs are diagnosed with cancer each year. The Veterinary Cancer Society estimates that 1 in 4 dogs will develop cancer at some point, and nearly 50% of dogs older than 10 will develop some form of cancer.

Download a free sample here – Veterinary Pain Management Market

Key Highlights of the Veterinary Pain Management Market

The veterinary pain management market is fragmented competitive with the presence of both international and local companies. Some of the market players include Ceva Santé Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol SA, and Boehringer Ingelheim International Gmbh.
In 2020, the United States Food & Drug Administration approved Cronus Pharma Specialties’ Carprofen Chewable Tablets (generic version of Rimadyl—Zoetis) for dogs. This nonsteroidal anti-inflammatory drug (NSAID) has been proven safe and effective in relieving pain and inflammation associated with osteoarthritis. Furthermore, it helps control postoperative pain associated with soft tissue and orthopedic surgeries.

Check our other latest research on –

Veterinary Healthcare Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)
Europe Veterinary Healthcare Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)

Recent Developments in the Veterinary Pain Management Market

In January 2022, the United States Food and Drug Administration (FDA) approved Zorbium (buprenorphine transdermal solution) from Elanco Animal Health as it expands its pain management offerings while addressing an unmet need for veterinary practices.
In January 2022, the United States Food and Drug Administration approved Solensia (frunevetmab injection), the first treatment for the control of pain associated with osteoarthritis in cats.

Related Research and Links

Farm Animal Healthcare Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)
Pet Care Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)

List of Key Players in the Veterinary Pain Management Market

Assisi Animal Health
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Chanelle Veterinary Limited
Dechra Pharmaceuticals PLC
Elanco Animal Health Incorporated
Norbrook
VetoquinolSA
Zoetis Inc.
Merck and Co Inc. 

*List Not Exhaustive

Mordor Intelligence has segmented the global veterinary pain management market based on product, application, animal type, end-user, and geography:

Product (Market Size & Forecast based on Revenue (USD million), 2019-2027)
Drugs
NSAIDS
Anesthetics
Opioids
Other Drugs

Devices
Laser Therapy
Electromagnetic Therapy

Application (Market Size & Forecast based on Revenue (USD million), 2019-2027)
Osteoarthritis and Joint Pain
Postoperative Pain
Cancer
Other Applications

Animal Type (Market Size & Forecast based on Revenue (USD million), 2019-2027)
Companion
Livestock

End-user (Market Size & Forecast based on Revenue (USD million), 2019-2027)
Hospitals and Clinics
Retail Outlets and Others

Geography (Market Size & Forecast based on Revenue (USD million), 2019-2027)
North America
US
Canada
Mexico

Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific

Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe

South America
Brazil
Argentina
Rest of South America

Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa

About Mordor Intelligence

Mordor Intelligence is a market intelligence and advisory firm. Our mission is to map complex business ecosystems across the globe to better predict butterfly effects. To date, we have partnered with 4000+ enterprises across 20 industries, to deliver precise data and actionable insights in over 6000 projects. Our domain-specific teams of research experts continuously track markets, enabling our clients to gain a competitive edge through high-quality market intelligence.

We offer fully tailored intelligence solutions to meet the unique business requirements of any organization. Our deep industry expertise coupled with cross-functional analyst teams ensures we can support the intelligence requirements of even the most specific of business problems.

Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Sai Teja
Email: Send Email
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/industry-reports/veterinary-pain-management-market?utm_source=press-release&utm_medium=Outbound&utm_campaign=62825&utm_id=AB_Newswire&utm_content=PR2